Randomized Trial for High-risk Cutaneous Squamous Cell Carcinoma Patients Treated With Adjuvant Cemiplimab
High-risk patients with cutaneous squamous cell carcinoma (CSCC) have an unmet need with regard to systemic adjuvant medical options after the gold standard of surgery and radiotherapy to redu...